Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks
Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol
Journal
The international journal of neuropsychopharmacology
Volume
13
Number
4
Pages / Article-Number
421-32
Mesh terms
Adult; Amygdala, drug effects; Cannabidiol, pharmacology; Double-Blind Method; Dronabinol, pharmacology; Emotions, drug effects; Facial Expression; Gyrus Cinguli, drug effects; Humans; Magnetic Resonance Imaging, methods; Male; Models, Neurological; Neural Pathways, drug effects; Placebos; Psychotropic Drugs, pharmacology
Abstract
Cannabis sativa, the most widely used illicit drug, has profound effects on levels of anxiety in animals and humans. Although recent studies have helped provide a better understanding of the neurofunctional correlates of these effects, indicating the involvement of the amygdala and cingulate cortex, their reciprocal influence is still mostly unknown. In this study dynamic causal modelling (DCM) and Bayesian model selection (BMS) were used to explore the effects of pure compounds of C. sativa [600 mg of cannabidiol (CBD) and 10 mg Delta 9-tetrahydrocannabinol (Delta 9-THC)] on prefrontal-subcortical effective connectivity in 15 healthy subjects who underwent a double-blind randomized, placebo-controlled fMRI paradigm while viewing faces which elicited different levels of anxiety. In the placebo condition, BMS identified a model with driving inputs entering via the anterior cingulate and forward intrinsic connectivity between the amygdala and the anterior cingulate as the best fit. CBD but not Delta 9-THC disrupted forward connectivity between these regions during the neural response to fearful faces. This is the first study to show that the disruption of prefrontal-subocritical connectivity by CBD may represent neurophysiological correlates of its anxiolytic properties.
